TKI258 for Metastatic Inflammatory Breast Cancer Patients
Condition: Breast CancerIntervention: Drug: DovitinibSponsors: M.D. Anderson Cancer Center; NovartisActive, not recruiting - verified December 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials